The US Food and Drug Administration (USFDA) has issued a Form 483 to Gland Pharma Ltd’s facility at JNPC, Visakhapatnam, following a pre-approval inspection of sterile APIs conducted between February 19 and February 25, 2025.
About the Author
The US Food and Drug Administration (USFDA) has issued a Form 483 to Gland Pharma Ltd’s facility at JNPC, Visakhapatnam, following a pre-approval inspection of sterile APIs conducted between February 19 and February 25, 2025.
